Cited 8 time in
Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kerry, Rout George | - |
| dc.contributor.author | Das, Gitishree | - |
| dc.contributor.author | Golla, Upendarrao | - |
| dc.contributor.author | del Pilar Rodriguez-Torres, Maria | - |
| dc.contributor.author | Shin, Han-Seung | - |
| dc.contributor.author | Patra, Jayanta Kumar | - |
| dc.date.accessioned | 2023-04-27T13:41:21Z | - |
| dc.date.available | 2023-04-27T13:41:21Z | - |
| dc.date.issued | 2022-01 | - |
| dc.identifier.issn | 1389-2010 | - |
| dc.identifier.issn | 1873-4316 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/3871 | - |
| dc.description.abstract | Nutritional supplementations are a form of nutrition sources that may help in improving the health complexities of a person throughout his or her life span. Being also categorized as food supplementations, nutraceuticals are products that are extracted from edible sources with medical benefits as well as primary nutritional values. Nutraceuticals can be considered as functional foods. There are evidences that nutraceutical supplementations can alter the commensal gut microbiota and help to prevent or fight against chronic non-communicable degenerative diseases in adults, including neurological disorders (Autism Spectrum Disorder [ASD], Parkinson's disease [PD], Multiple sclerosis [MS]) and metabolic disorders (Type-II diabetes, obesity and non-alcoholic fatty liver disease). They can even lessen the complexities of preterm babies like extra-uterine growth restriction, necrotizing enterocolitis, infant eczema and allergy (during pregnancy) as well as bronchopulmonary dysplasia. Molecular perception of inflammatory and apoptotic modulators regulating the pathogenesis of these health risks, their control and management by probiotics and prebiotics could further emphasize the scientific overview of their utility. In this study, the pivotal role of nutraceutical supplementations in regulating or modulating molecular pathways in the above non-communicable diseases is briefly described. This work also gives an overall introduction of the sophisticated genome-editing techniques and advanced delivery systems in therapeutic activities applicable under these health risks. | - |
| dc.format.extent | 26 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Bentham Science Publishers | - |
| dc.title | Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review | - |
| dc.type | Article | - |
| dc.publisher.location | 아랍에미리트 | - |
| dc.identifier.doi | 10.2174/1389201021666201013153142 | - |
| dc.identifier.scopusid | 2-s2.0-85101940321 | - |
| dc.identifier.wosid | 000737929900007 | - |
| dc.identifier.bibliographicCitation | Current Pharmaceutical Biotechnology, v.23, no.1, pp 72 - 97 | - |
| dc.citation.title | Current Pharmaceutical Biotechnology | - |
| dc.citation.volume | 23 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 72 | - |
| dc.citation.endPage | 97 | - |
| dc.type.docType | Review | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | FATTY LIVER-DISEASE | - |
| dc.subject.keywordPlus | EXTRAUTERINE GROWTH RESTRICTION | - |
| dc.subject.keywordPlus | GUT MICROBIOTA | - |
| dc.subject.keywordPlus | NECROTIZING ENTEROCOLITIS | - |
| dc.subject.keywordPlus | MULTIPLE-SCLEROSIS | - |
| dc.subject.keywordPlus | GENE-EXPRESSION | - |
| dc.subject.keywordPlus | DOUBLE-BLIND | - |
| dc.subject.keywordPlus | BRONCHOPULMONARY DYSPLASIA | - |
| dc.subject.keywordPlus | OPTIMIZING NUTRITION | - |
| dc.subject.keywordPlus | INSULIN SENSITIVITY | - |
| dc.subject.keywordAuthor | Nutraceutical supplementation | - |
| dc.subject.keywordAuthor | probiotics | - |
| dc.subject.keywordAuthor | prebiotics | - |
| dc.subject.keywordAuthor | genome editing | - |
| dc.subject.keywordAuthor | delivery systems | - |
| dc.subject.keywordAuthor | diabetes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
